Wang Y, Taub M
Biochemistry Department, State University of New York, Buffalo 14214.
J Cell Physiol. 1991 May;147(2):374-82. doi: 10.1002/jcp.1041470224.
Insulin was observed to modulate the growth and the phosphoenolpyruvate carboxykinase (PEPCK) activity of primary cultures of rabbit renal proximal tubule cells in serum free medium. Insulin was stimulatory to primary proximal tubule cell growth at a concentration of 10(-8) M. In contrast, insulin was inhibitory to a proximal tubule function, PEPCK activity, following a 5-minute incubation period. An insulin dosage as low as 10(-10) M was inhibitory to PEPCK activity, suggesting the involvement of insulin receptors. Although insulin was required at a significantly higher dosage to stimulate the growth of the primary renal proximal tubule cells than to inhibit PEPCK activity, the elevated dosage required in order to observe a growth effect may be explained by the degradation of insulin by the primary renal proximal tubule cells. However the possible involvement of receptors for Insulin-like Growth Factor I (IGF-I) and Insulin-like Growth Factor II (IGF-II) in mediating the effects of insulin cannot be excluded. Other effector molecules were also examined with respect to their effects on PEPCK activity. The possible involvement of cyclic AMP in the control of the PEPCK activity of the primary renal cells was indicated by the stimulatory effects of 8 bromocyclic AMP, isobutyl methylxanthine (a cyclic AMP phosphodiesterase inhibitor), and forskolin (an activator of adenylate cyclase). Phorbol 12-myristate 13-acetate (TPA), which activates protein kinase C, was inhibitory. The actions of these effector molecules and insulin on the PEPCK activity of the primary renal cultures are remarkably similar to their effects on hepatic PEPCK. Several growth factors, fibroblast growth factor (FGF), and transforming growth factor beta (TGF beta) were also examined. FGF was observed to be stimulatory, whereas TGF beta was inhibitory to the PEPCK activity of the primary renal proximal tubule cells.
在无血清培养基中,观察到胰岛素可调节兔肾近端小管细胞原代培养物的生长及磷酸烯醇丙酮酸羧激酶(PEPCK)活性。胰岛素在浓度为10^(-8)M时对原代近端小管细胞生长具有刺激作用。相反,在孵育5分钟后,胰岛素对近端小管功能即PEPCK活性具有抑制作用。低至10^(-10)M的胰岛素剂量即可抑制PEPCK活性,提示胰岛素受体参与其中。尽管刺激原代肾近端小管细胞生长所需的胰岛素剂量明显高于抑制PEPCK活性所需剂量,但为观察到生长效应而需要的较高剂量可能是由于原代肾近端小管细胞对胰岛素的降解所致。然而,不能排除胰岛素样生长因子I(IGF-I)和胰岛素样生长因子II(IGF-II)的受体可能参与介导胰岛素的作用。还研究了其他效应分子对PEPCK活性的影响。8-溴环磷酸腺苷、异丁基甲基黄嘌呤(一种环磷酸腺苷磷酸二酯酶抑制剂)和福斯高林(一种腺苷酸环化酶激活剂)的刺激作用表明环磷酸腺苷可能参与原代肾细胞PEPCK活性的调控。激活蛋白激酶C的佛波酯12-肉豆蔻酸酯13-乙酸酯(TPA)具有抑制作用。这些效应分子和胰岛素对原代肾培养物PEPCK活性的作用与其对肝PEPCK的作用非常相似。还研究了几种生长因子,即成纤维细胞生长因子(FGF)和转化生长因子β(TGFβ)。观察到FGF具有刺激作用,而TGFβ对原代肾近端小管细胞的PEPCK活性具有抑制作用。